The Real Impact of Peripheral Artery Disease in TAVR

Courtesy of Dr. Carlos Fava.

The real incidence of peripheral artery (PAD) disease in TAVR remains unclear. Different reports still estimate it is between 10 and 46%, but they have shown it has a negative impact in evolution.

Protrusión de placa en angioplastia carotidea ¿Qué riesgo implica y cómo prevenirlo?

51,685 TAVR patients were analyzed. 12,740 of these patients presented PAD (24.6%).

PAD patients tended to be younger, mostly men, smokers, hypertensive, with a history of cardiovascular and carotid disease, chronic obstructive pulmonary disease (COPD), kidney function deterioration and cardiovascular revascularization. There were no differences in obesity and diabetes. In this group, TAVR was done more often in university hospitals.


Read also: ESC 2019 | How Benign Is Moderate Aortic Stenosis?


At hospital level, there were no differences in mortality, need for pacemaker, acute myocardial infarction (AMI), or conversion to surgery. But the presence of PAD was associated to vascular complications [8.6 vs. 5.3%, OR 1.80 (1.50–2.16), p < 0.001], major bleeding [10.8 vs. 8.8%, OR 1.20 (1.09–1.34), p < 0.001], kidney function deterioration [18.2 vs. 15.6%, OR 1.19 (1.05–1.36), p=0.007], cardiac complications [9.4 vs. 8.2%, OR 1.21 (1.01–1.44), p=0.03], stroke [3.2 vs. 2.7%, OR 1.39(1.10–1.75), p=0.005] and longer in-hospital stay [7.23 (0.14) days vs. 7.11 (0.1) days, p < 0.001].

Conclusion

The presence of PAD in TAVR is 25% approximately. This disease was not associated to increased in-hospital mortality, but it was associated to higher risk of vascular complications, major bleeding, kidney function deterioration, stroke, cardiac complications and longer in-hospital stay.

Courtesy of Dr. Carlos Fava.


Original title: Association of peripheral artery disease with in-hospital outcomes after endovascular transcatheter aortic valve replacement.

Reference; Divyanshu Mohananey, et, al. Catheter Cardiovasc Interv 2019;94:249-255.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...